Patel, D. P., Toulabi, L., Casiano, A. S., Dorsey, T., Khan, M., Harris, C., Ambs, S., Wang, X. W. (2026). Urinary creatine riboside for risk stratification of clinically significant prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17149